Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Sight Sciences
SGHT
$456M
| $517K | ﹤0.01% |
65,250
+6,094
| +10% | +$38.9K |
|
3777
Tejon Ranch
TRC
$441M
| $517K | ﹤0.01% |
32,787
+3,166
| +11% | +$50.5K |
|
3778
eGain
EGAN
$200M
| $516K | ﹤0.01% |
50,136
-10,177
| -17% | -$122K |
|
3779
MBIA
MBI
$254M
| $515K | ﹤0.01% |
71,911
+7,578
| +12% | +$54.8K |
|
3780
Compass Diversified
CODI
$908M
| $514K | ﹤0.01% |
107,076
-105,294
| -50% | -$665K |
|
3781
Sprott Uranium Miners ETF
URNM
$2.03B
| $513K | ﹤0.01% |
9,353
+7,879
| +535% | +$455K |
|
3782
Kura Sushi USA
KRUS
$637M
| $512K | ﹤0.01% |
9,793
+804
| +9% | +$43.9K |
|
3783
Waterstone Financial
WSBF
$378M
| $512K | ﹤0.01% |
30,924
+750
| +2% | +$11.8K |
|
3784
CB Financial Services
CBFV
$192M
| $508K | ﹤0.01% |
14,577
+701
| +5% | +$23.8K |
|
3785
Acco Brands
ACCO
$399M
| $508K | ﹤0.01% |
136,080
+13,013
| +11% | +$48.3K |
|
3786
Franklin Covey
FC
$234M
| $506K | ﹤0.01% |
30,174
+10,612
| +54% | +$178K |
|
3787
Velocity Financial
VEL
$711M
| $506K | ﹤0.01% |
24,362
+2,661
| +12% | +$50K |
|
3788
Holley
HLLY
$384M
| $506K | ﹤0.01% |
122,456
+38,564
| +46% | +$139K |
|
3789
Village Super Market
VLGEA
$627M
| $505K | ﹤0.01% |
14,274
+1,393
| +11% | +$47.8K |
|
3790
OraSure Technologies
OSUR
$259M
| $505K | ﹤0.01% |
208,625
+70,985
| +52% | +$187K |
|
3791
Contango Silver & Gold Inc
CTGO
$657M
| $505K | ﹤0.01% |
19,109
+4,451
| +30% | +$109K |
|
3792
JELD-WEN Holding
JELD
$164M
| $504K | ﹤0.01% |
204,995
+33,824
| +20% | +$111K |
|
|
CTEV
3793
Claritev Corp
CTEV
$599M
| $504K | ﹤0.01% |
11,793
+157
| +1% | +$7.99K |
|
3794
FRP Holdings
FRPH
$425M
| $503K | ﹤0.01% |
22,054
+3,441
| +18% | +$81.3K |
|
3795
SITE Centers
SITC
$156M
| $502K | ﹤0.01% |
78,141
+7,148
| +10% | +$54K |
|
3796
Ponce Financial Group
PDLB
$500M
| $502K | ﹤0.01% |
30,673
+2,906
| +10% | +$44.8K |
|
|
JAPN
3797
Horizon Kinetics Japan Owner Operator ETF
JAPN
$26.3M
| $501K | ﹤0.01% |
19,500
+14,000
| +255% | +$375K |
|
3798
Denison Mines
DNN
$2.98B
| $500K | ﹤0.01% |
188,021
+25,890
| +16% | +$70.4K |
|
|
BIOA
3799
BioAge Labs
BIOA
$481M
| $500K | ﹤0.01% |
37,780
+3,222
| +9% | +$28.6K |
|
3800
Fossil Group
FOSL
$311M
| $498K | ﹤0.01% |
132,459
+54,862
| +71% | +$155K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.